Impact of Primary Tumour Location on Second- Or Later-Line Treatment Outcomes in Patients With RAS Wild-Type Metastatic Colorectal Cancer and in All Lines of Treatment in Patients With RAS Mutations in Four Randomised Panitumumab Studies
Clinical Colorectal Cancer - United States
doi 10.1016/j.clcc.2018.03.005
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2018
Authors
Publisher
Elsevier BV